Navigation Links
Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
Date:5/16/2008

openia.

About Nektar

Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development technology platforms. Nektar PEGylation and pulmonary technology, expertise, manufacturing capabilities have enabled eight approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its PEGylation and pulmonary technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.

This press release contains forward-looking statements regarding the potential of NKTR-102 and Nektar's PEGylation technology platform. These forward-looking statements involve important risks and uncertainties, including but not limited to: (i) clinical trials for NKTR-102 are long, expensive and uncertain processes; (ii) because NKTR-102 is in the early phases of clinical development, the risk of failure is high and can occur at any stage of development regardless of promising data from one or more prior preclinical or clinical studies, (iii) the timing or success of the commencement or end of clinical trials may be delayed or unsuccessful due to slower than anticipated patient enrollment, drug manufacturing challenges, changing standards of care, clinical trial design, and/or clinical outcomes; (iv) Nektar may fail to obtain regulatory approval of NKTR-102; (v) potential competition from existing approved products (branded or generic) or product candidates under development by other companies could negatively impact the commercial potential of NKTR-102 due to such common industry competitive factors as efficacy and safety profiles, pricing, and reimbursement by third party payers; and (vi) Nektar's patent applications for NKTR-102 may fail to issue; patents that have issued may not be enforceable; or unanticipat
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 In ... the Canadian International Pharmacy Association (CIPA) ... online from licensed Canadian pharmacies. Approximately 64% of respondents ... medications from a non-U.S. pharmacy due to costs ... not covered under their insurance plan.   ...
(Date:5/27/2015)... , May 27, 2015  Genomic Health, Inc. (Nasdaq: ... Operating Officer and Chief Financial Officer, will present at the ... City on Monday, June 1 at 8:30 a.m. ... subsequently archived webcast of the presentation, go to the  Investor ... .  Please connect to the web site at least 15 ...
(Date:5/27/2015)...  Later this week, Cardinal Health Specialty Solutions ... outcomes research (HEOR) studies that reinforce the importance ... reimbursement strategies.   Dr. Bruce ... of Cardinal Health Specialty Solutions, says that physicians, ... more than a decade that clinical trials alone ...
Breaking Medicine Technology:Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies 2New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies 3
...  NxStage Medical, Inc. (Nasdaq: NXTM ), a ... to release its financial results for the fourth quarter ... February 29, 2012  before the opening of the financial ... NxStage will also host a conference call at ...
... (OTC BB: IVOB), a medical device company focused on ... that the National Health Surveillance Agency (ANVISA) in Brazil ... a Class II device. This approval allows the INVOcell ... Brazil and marks a major milestone in the history ...
Cached Medicine Technology:NxStage® to Report Fourth Quarter and Full Year 2011 Financial Results 2INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA 2INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA 3
(Date:5/27/2015)... The news is full of companies getting fined, ... or appropriate training: an automobile manufacturer, a store in ... in Texas and the list goes on. The Feds ... to improper training and documentation (Osha.gov). eLeaP Learning ... new Supervisor feature which provides a powerful tool for ...
(Date:5/27/2015)... May 27, 2015 Altec Products, Inc., ... announced today their Premier Sponsorship of Connections 2015. The ... Hilton on Thursday, May 28th and will deliver to ... well as the roadmap to get there. , ... in the sale, installation and support of Intacct Cloud ...
(Date:5/27/2015)... Harbor, MD (PRWEB) May 27, 2015 ... will attend this year’s conference of the American Immigration ... at the Gaylord National Resort. MCA’s booth is #404. ... Annual Gathering in Immigration Law.” MCAads.com, a regular AILA ... family meeting” as they welcome current clients to their ...
(Date:5/27/2015)... The Society for Women's Health Research ... research on sex differences in health and disease, today ... advocates, organizations, and celebrities in bringing awareness to the ... campaign features a short film that shares the stories ... as a result of their abuse, as well as ...
(Date:5/27/2015)... 27, 2015 A. Joshua Halpern, MD, ... the addition of UltraShape® , a revolutionary body-shaping ... his Tampa Plastic Surgery Center. , ... the first and only non-invasive body shaping treatment that ... fat, without harming the surrounding tissue, vasculature, nerves or ...
Breaking Medicine News(10 mins):Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 2Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 3Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 2Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 3Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 2Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 3Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 2Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 3Health News:Tampa Plastic Surgery Center Delivers A Better Way To A Better Body 2Health News:Tampa Plastic Surgery Center Delivers A Better Way To A Better Body 3
... 23 Alexandra Rundlett and Gregory Laslo will travel ... 31, 2009 to meet with congressional leaders and gain ... research toward a cure for epilepsy.Rundlett, 10, and Laslo, ... in Kids Speak Up! , a national program ...
... SAN FRANCISCO, March 23 Blue Shield of California ... Tuesday, promoting Rob Geyer and Janet Widmann to senior ... previous changes announced by chairman and CEO Bruce Bodaken ... chief operating officer. Geyer, previously vice president of ...
... possess an enzyme deficiency that causes their skin to ... from the National Institute on Alcohol Abuse and Alcoholism ... heavy alcohol consumption greatly increases the risk for esophageal ... of the world,s population. Their review of recent research ...
... Claire Kenney of Boise, Idaho, will travel to Washington, ... to meet with congressional leaders and gain their support ... a cure for epilepsy.Kennedy, 16, is one of 37 ... Kids Speak Up! , a national program coordinated by ...
... UnionEAST PROVIDENCE, R.I., March 23 IlluminOss Medical ... IlluminOss(TM) Photodynamic Bone Stabilization System for orthopedic surgery, ... CE Mark. The approval permits the Company ... (EU).IlluminOss Medical is beginning the process of selecting ...
... March 23 Kiley Carlson of Sioux City, IA ... Tuesday, March 31, 2009 to meet with congressional leaders ... and more research toward a cure for epilepsy.Carlson, 16, ... country participating in Kids Speak Up! , a ...
Cached Medicine News:Health News:Maryland Youths Share Epilepsy Message on Capitol Hill 2Health News:Blue Shield of California Names Two New Senior Vice Presidents 2Health News:Alcohol 'flush' signals increased cancer risk among East Asians 2Health News:Alcohol 'flush' signals increased cancer risk among East Asians 3Health News:Idaho Youth Shares Epilepsy Message on Capitol Hill 2Health News:IlluminOss(TM) Photodynamic Bone Stabilization System Receives CE Mark 2Health News:Iowa Youth Shares Epilepsy Message on Capitol Hill 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: